Introduction
Neurons comprise the soma, axons, and dendrites. The latter two are collectively known as neurites, in which molecules including proteins are synthesized, delivered, and degraded for their dynamic functions in synaptic growth and activity. Upon specific stimuli, the axons and dendrites of cultured neurons exhibit features of degeneration, including terminal degradation, neurite retraction, synaptic pathology, and marked focal beading or swelling. The term 'dystrophic neurites' is used to describe these processes, and is analogous to neurite dystrophy in vivo. In neurodegenerative disorders, axons, dendrites, and synapses often degenerate before the loss of the cell bodies, and this may contribute to preclinical episodes of disease process and eventual clinical symptoms [1, 2] .
Autophagy is a self-digestion system that is responsible for the clearance of long-lived proteins and damaged organelles by the lysosome. A group of evolutionarily conserved gene products, known as the Atg (autophagyrelated gene) proteins, are required for autophagosome (autophagic vacuole; see Glossary) synthesis, maturation, trafficking, and clearance [3] . Several functionally distinct groups are responsible for autophagy execution, including the Ulk1-Atg13-FIP200 kinase complex, the class III phosphoinositide 3-kinase (PI3K-III) complex containing the core proteins Vps34, p150, and beclin 1, the lipid-binding Atg18 homologs, the multi-spanning transmembrane protein Atg9, the Atg12 conjugation system, and the ubiquitin-like LC3 conjugation system [3] . Examples of upstream signaling molecules that regulate autophagy activity include the mammalian target of rapamycin (mTOR), a Ser/Thr kinase which prevents autophagy induction through Ulk1 inactivation, and AMP-activated protein kinase (AMPK), an energy-sensing kinase that promotes autophagy by inducing Ulk1 activation [4] . Pharmacological induction of autophagy can be achieved using rapamycin, which inhibits mTOR. In addition, the class III PI3K-beclin 1 complex controls the nucleation process of the phagophore, a precursor of the autophagosome. 3-Methyladenine (3-MA), or wortmannin, which inhibit class III PI3K activity, are often used to block autophagy.
Emerging evidence demonstrates that macroautophagy (hereafter referred to as 'autophagy') plays a critical role in the maintenance of protein and organelle homeostasis in the axons and protection of axons. Dysfunctional
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Glossary
Anterograde transport:: from the cell body to the axonal or dendritic terminals, is carried out mostly by kinesin superfamilies, which are plus-enddirected motors [95] . Autolysosome:: a single-membrane vesicle that forms at a late stage of the autophagy pathway by fusion of autophagosomes with endosomes or lysosomes [96] . Autophagosome:: a double-membrane vesicle that forms at an early stage of the autophagy pathway and fuses with endosomes and lysosomes for degradation of its contents [97] . Axonal dystrophy:: characterized by either focal dilations that interrupt the continuity of axons or terminal end bulbs in dysfunctional or degenerating neurons. Dying-back degeneration:: degeneration initiates from the distal ends of axons, following by distal-to-proximal progression. 
